Regulatory mechanism and promising clinical application of exosomal circular RNA in gastric cancer

Front Oncol. 2023 Nov 29:13:1236679. doi: 10.3389/fonc.2023.1236679. eCollection 2023.

Abstract

Gastric cancer (GC) is one of the most common malignancies worldwide and the leading cause of cancer-related deaths. Exosomes are nanoscale extracellular vesicles secreted by a variety of cells and play an important role in cellular communication and epigenetics by transporting bioactive substances in the tumor microenvironment (TME). Circular RNA (circRNA) is a type of non-coding RNA (ncRNA) with a specific structure, which is widely enriched in exosomes and is involved in various pathophysiological processes mediated by exosomes. Exosomal circRNAs play a critical role in the development of GC by regulating epithelial-mesenchymal transition (EMT), angiogenesis, proliferation, invasion, migration, and metastasis of GC. Given the biological characteristics of exosomal circRNAs, they have more significant diagnostic sensitivity and specificity in the clinic and may become biomarkers for GC diagnosis and prognosis. In this review, we briefly describe the biogenesis of exosomes and circRNAs and their biological functions, comprehensively summarize the mechanisms of exosomal circRNAs in the development of GC and chemotherapy resistance, and finally, we discuss the potential clinical application value and challenges of exosomal circRNAs in GC.

Keywords: biomarkers; chemotherapy resistance; epithelial-mesenchymal transition; exosomal circRNAs; gastric cancer.

Publication types

  • Review

Grants and funding

This study was financially supported by the Natural Science Foundation of Shanghai Science and Technology Commission (No. 20ZR1459300). Heathcote-Henry Oncology Research Fund. The Special Fund of Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine (No.2021yygm06), the Key Project of Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine (No.2019YY201), and Shanghai Municipal Hospital Gastroenterclogy clinical competence improvement and advancement specialist alliance (SHDC22021311) Special Construction of Traditional Chinese Medicine Advantage Specialty (YW(2023-2024)-01-08).